Russell Schundler
Known title: General CounselCIK: 0001854414
Russell Schundler's purchase track record
Russell Schundler has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/10/2021 | LQDA | $497K | +56.7% | +16.6% | -15.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| LQDA | ▼ Sell | Open Market | 1,046 | $75K | 7/13/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 13,692 | $979K | 7/13/2026 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 6,409 | — | 7/10/2026 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 3,759 | — | 7/10/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 13,692 | $525K | 4/13/2026 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 3,758 | — | 4/10/2026 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 6,409 | — | 4/10/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 1,073 | $33K | 3/2/2026 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 2,344 | — | 2/27/2026 | View on chart |
| LQDA | ▲ Buy | Grant | 32,955 | $0 | 1/16/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 27,289 | $1.0M | 1/12/2026 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 25,636 | — | 1/9/2026 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 3,759 | — | 1/9/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 1,072 | $35K | 12/1/2025 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 2,343 | — | 11/28/2025 | View on chart |
| LQDA | ▼ Sell | Open Market | 7,839 | $184K | 10/13/2025 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 3,758 | — | 10/10/2025 | View on chart |
| LQDA | ▼ Sell | Open Market | 1,063 | $31K | 9/2/2025 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 2,344 | — | 8/29/2025 | View on chart |
| LQDA | ▼ Sell | Open Market | 7,836 | $112K | 7/14/2025 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 3,759 | — | 7/11/2025 | View on chart |
| LQDA | ▼ Sell | Open Market | 8,460 | $144K | 6/4/2025 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 18,792 | — | 6/3/2025 | View on chart |
| LQDA | ▼ Sell | Open Market | 923 | $15K | 6/2/2025 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 2,344 | — | 5/30/2025 | View on chart |
| LQDA | ▼ Sell | Open Market | 5,964 | $81K | 4/14/2025 | View on chart |
| LQDA | ▼ Sell | Open Market | 930 | $14K | 3/3/2025 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 2,344 | — | 2/28/2025 | View on chart |
| LQDA | ▼ Sell | Open Market | 16,393 | $193K | 1/14/2025 | View on chart |
| LQDA | ▲ Buy | Grant | 102,543 | $0 | 1/11/2025 | View on chart |
| LQDA | ▼ Sell | Open Market | 1,063 | $12K | 12/2/2024 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 2,343 | — | 11/30/2024 | View on chart |
| LQDA | ▼ Sell | Open Market | 2,576 | $29K | 10/14/2024 | View on chart |
| LQDA | ▼ Sell | Open Market | 710 | $7K | 9/3/2024 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 2,344 | — | 8/30/2024 | View on chart |
| LQDA | ▼ Sell | Open Market | 1,985 | $25K | 7/12/2024 | View on chart |
| LQDA | ▼ Sell | Open Market | 710 | $10K | 6/3/2024 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 2,344 | — | 5/31/2024 | View on chart |
| LQDA | ▼ Sell | Open Market | 2,060 | $30K | 4/12/2024 | View on chart |
| LQDA | ▼ Sell | Open Market | 7,938 | $126K | 3/18/2024 | View on chart |
| LQDA | ▼ Sell | Open Market | 715 | $11K | 3/18/2024 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 2,344 | — | 3/15/2024 | View on chart |
| LQDA | ▲ Buy | Grant | 110,135 | $0 | 1/11/2024 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 2,343 | — | 11/30/2023 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 2,344 | — | 8/31/2023 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 2,344 | — | 5/31/2023 | View on chart |
| LQDA | ▲ Buy | Option Exercise | 9,375 | — | 2/28/2023 | View on chart |
| LQDA | ▲ Buy | Grant | 104,167 | $0 | 1/11/2023 | View on chart |
| LQDA | ▲ Buy | Grant | 600 | $3K | 9/6/2022 | View on chart |
| LQDA | ▲ Buy | Grant | 32,000 | $182K | 9/6/2022 | View on chart |
| LQDA | ▲ Buy | Grant | 2,166 | $11K | 8/31/2022 | View on chart |
| LQDA | ▲ Buy | Grant | 2,158 | $0 | 3/31/2022 | View on chart |
| LQDA | ▲ Buy | Open Market | 18,008 | $76K | 11/10/2021 | View on chart |
| LQDA | ▲ Buy | Open Market | 39,900 | $171K | 11/10/2021 | View on chart |
| LQDA | ▲ Buy | Open Market | 60,000 | $251K | 11/10/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Liquidia shares fall on patent court loss and analyst downgrades
Liquidia stock is down sharply after a court ruling regarding YUTREPIA patent access, which analysts say clouds the drug's future. Wells Fargo downgraded the stock to Equal-Weight and lowered its price target to $30, while other analysts also cut their targets. The stock is currently trading near its 52-week low, reflecting significant market concern over the legal outcome.
Liquidia shares fall on patent court loss and analyst downgrades. Liquidia stock is down sharply after a court ruling regarding YUTREPIA patent access, which analysts say clouds the drug's future. Wells Fargo downgraded the stock to Equal-Weight and lowered its price target to $30, while other analysts also cut their targets. The stock is currently trading near its 52-week low, reflecting significant market concern over the legal outcome.